18
Participants
Start Date
May 10, 2011
Primary Completion Date
May 29, 2012
Study Completion Date
October 31, 2033
autologous CAR.CD30 EBV specific-CTLs
Three dose levels will be evaluated. Using the modified continual reassessment method, cohorts of size two will be enrolled at each dose level. Each patient will receive one injection.
Houston Methodist Hospital, Houston
Texas Children's Hospital, Houston
Center for Cell and Gene Therapy, Baylor College of Medicine
OTHER
The Methodist Hospital Research Institute
OTHER
Baylor College of Medicine
OTHER